Blau Farmacêutica Statistics

Total Valuation

Blau Farmacêutica has a market cap or net worth of BRL 2.48 billion. The enterprise value is 2.65 billion.

Market Cap	2.48B
Enterprise Value	2.65B

Important Dates

The next estimated earnings date is Tuesday, November 5, 2024.

Earnings Date	Nov 5, 2024
Ex-Dividend Date	Jun 27, 2024

Share Statistics

Blau Farmacêutica has 177.68 million shares outstanding. The number of shares has increased by 0.24% in one year.

Shares Outstanding	177.68M
Shares Change (YoY)	+0.24%
Shares Change (QoQ)	-4.01%
Owned by Insiders (%)	83.30%
Owned by Institutions (%)	5.81%
Float	29.68M

Valuation Ratios

The trailing PE ratio is 11.36 and the forward PE ratio is 10.08. Blau Farmacêutica's PEG ratio is 0.72.

PE Ratio	11.36
Forward PE	10.08
PS Ratio	1.57
PB Ratio	1.21
P/FCF Ratio	19.77
PEG Ratio	0.72

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 7.45, with an EV/FCF ratio of 21.17.

EV / Earnings	12.18
EV / Sales	1.68
EV / EBITDA	7.45
EV / EBIT	8.47
EV / FCF	21.17

Financial Position

The company has a current ratio of 3.98, with a Debt / Equity ratio of 27.55.

Current Ratio	3.98
Quick Ratio	2.59
Debt / Equity	27.55
Debt / EBITDA	1.58
Debt / FCF	4.48
Interest Coverage	5.77

Financial Efficiency

Return on equity (ROE) is 10.92% and return on invested capital (ROIC) is 8.30%.

Return on Equity (ROE)	10.92%
Return on Assets (ROA)	6.98%
Return on Capital (ROIC)	8.30%
Revenue Per Employee	828,897
Profits Per Employee	114,569
Employee Count	1,900
Asset Turnover	0.56
Inventory Turnover	1.91

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -17.57% in the last 52 weeks. The beta is 0.45, so Blau Farmacêutica's price volatility has been lower than the market average.

Beta (5Y)	0.45
52-Week Price Change	-17.57%
50-Day Moving Average	12.21
200-Day Moving Average	12.13
Relative Strength Index (RSI)	59.04
Average Volume (20 Days)	403,450

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Blau Farmacêutica had revenue of BRL 1.57 billion and earned 217.68 million in profits. Earnings per share was 1.23.

Revenue	1.57B
Gross Profit	520.57M
Operating Income	312.67M
Pretax Income	292.54M
Net Income	217.68M
EBITDA	350.64M
EBIT	312.67M
Earnings Per Share (EPS)	1.23

Full Income Statement

Balance Sheet

The company has 376.38 million in cash and 560.39 million in debt, giving a net cash position of -184.01 million or -1.04 per share.

Cash & Cash Equivalents	376.38M
Total Debt	560.39M
Net Cash	-184.01M
Net Cash Per Share	-1.04
Equity (Book Value)	2.03B
Book Value Per Share	11.50
Working Capital	1.12B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 237.57 million and capital expenditures -112.40 million, giving a free cash flow of 125.17 million.

Operating Cash Flow	237.57M
Capital Expenditures	-112.40M
Free Cash Flow	125.17M
FCF Per Share	0.70

Full Cash Flow Statement

Margins

Gross margin is 33.05%, with operating and profit margins of 19.85% and 13.71%.

Gross Margin	33.05%
Operating Margin	19.85%
Pretax Margin	18.57%
Profit Margin	13.71%
EBITDA Margin	22.26%
EBIT Margin	19.85%
FCF Margin	7.95%

Dividends & Yields

This stock pays an annual dividend of 0.75, which amounts to a dividend yield of 5.52%.

Dividend Per Share	0.75
Dividend Yield	5.52%
Dividend Growth (YoY)	-63.51%
Years of Dividend Growth	n/a
Payout Ratio	26.50%
Buyback Yield	-0.24%
Shareholder Yield	5.28%
Earnings Yield	8.80%
FCF Yield	5.06%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a